Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
133.13
1.82 (1.39%)
At close: Aug 15, 2025, 1:28 PM
Neurocrine Biosciences Fail-to-Deliver
Total FTD Shares
2.54K
Below Average
FTD / Avg. Volume
0.26%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Neurocrine Biosciences Inc. has
2,535
shares failed to deliver, representing 0.26%
of the average daily volume of
962,793
shares. Over the past year, the monthly average FTD is
3,699
shares, with the current level 31% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 135.13 | 2.54K | +198.24% |
Jun 26, 2025 | 126.71 | 850 | +1114.29% |
May 30, 2025 | 123.02 | 70 | -99.25% |
Apr 25, 2025 | 106.73 | 9.37K | +2901.60% |
Mar 31, 2025 | 110.6 | 312 | -83.28% |
Feb 27, 2025 | 117.51 | 1.87K | -44.17% |
Jan 24, 2025 | 148.73 | 3.34K | +4607.04% |
Dec 31, 2024 | 136.5 | 71 | +238.10% |
Nov 22, 2024 | 125.65 | 21 | -67.69% |
Oct 24, 2024 | 115.52 | 65 | +333.33% |
Sep 27, 2024 | 115.06 | 15 | -89.51% |
Aug 12, 2024 | 147.29 | 143 | -28.50% |
Jul 29, 2024 | 145.25 | 200 | +33.33% |
Jun 18, 2024 | 130.86 | 150 | +14900.00% |
May 30, 2024 | 136.66 | 1 | -97.44% |
Apr 29, 2024 | 138.89 | 39 | +225.00% |
Mar 27, 2024 | 137.83 | 12 | -55.56% |
Feb 22, 2024 | 133.37 | 27 | -95.92% |
Jan 30, 2024 | 142.06 | 661 | +160.24% |
Dec 28, 2023 | 132.15 | 254 | -81.24% |
Nov 22, 2023 | 110.98 | 1.35K | -45.84% |
Oct 24, 2023 | 109.25 | 2.5K | +7964.52% |
Sep 14, 2023 | 113.78 | 31 | -65.56% |
Aug 14, 2023 | 105.56 | 90 | +1025.00% |
Jul 31, 2023 | 101.89 | 8 | -99.32% |
Jun 30, 2023 | 94.3 | 1.17K | +237.75% |
May 31, 2023 | 89.53 | 347 | -73.57% |
Apr 27, 2023 | 101.9 | 1.31K | +2526.00% |
Mar 30, 2023 | 99.21 | 50 | -99.15% |
Feb 27, 2023 | 102.2 | 5.88K | +1891.86% |
Jan 31, 2023 | 110.93 | 295 | n/a |